IT7851570A0 - PROCEDURE FOR THE PRODUCTION OF IMIDAZOLE DERIVATIVES PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENT - Google Patents
PROCEDURE FOR THE PRODUCTION OF IMIDAZOLE DERIVATIVES PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENTInfo
- Publication number
- IT7851570A0 IT7851570A0 IT7851570A IT5157078A IT7851570A0 IT 7851570 A0 IT7851570 A0 IT 7851570A0 IT 7851570 A IT7851570 A IT 7851570A IT 5157078 A IT5157078 A IT 5157078A IT 7851570 A0 IT7851570 A0 IT 7851570A0
- Authority
- IT
- Italy
- Prior art keywords
- procedure
- contain
- production
- active ingredient
- pharmaceutical compositions
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4353277 | 1977-10-19 | ||
| GB4351277 | 1977-10-19 | ||
| GB398478 | 1978-02-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT7851570A0 true IT7851570A0 (en) | 1978-10-18 |
| IT1109321B IT1109321B (en) | 1985-12-16 |
Family
ID=27254350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT51570/78A IT1109321B (en) | 1977-10-19 | 1978-10-18 | PROCEDURE FOR THE PRODUCTION OF IMIDAZOLIC DERIVATIVES PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AS AN ACTIVE INGREDIENT |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5488268A (en) |
| AT (1) | AT370095B (en) |
| AU (1) | AU522055B2 (en) |
| CA (1) | CA1111433A (en) |
| DE (1) | DE2845406A1 (en) |
| DK (1) | DK464278A (en) |
| FI (1) | FI783175A (en) |
| IE (1) | IE47749B1 (en) |
| IL (1) | IL55858A (en) |
| IT (1) | IT1109321B (en) |
| MC (1) | MC1221A1 (en) |
| ZA (1) | ZA785863B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
| US4430445A (en) | 1979-07-19 | 1984-02-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin |
| JPS6047257B2 (en) * | 1979-07-19 | 1985-10-21 | 旭化成株式会社 | Novel basic substances and their production methods |
| JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
| GR78234B (en) * | 1981-03-10 | 1984-09-26 | Ciba Geigy Ag | |
| JPS57188570A (en) * | 1981-05-14 | 1982-11-19 | Shionogi & Co Ltd | Benzylazole derivative |
| ZA835967B (en) * | 1982-08-14 | 1985-04-24 | Wellcome Found | Imidazole derivatives and salts thereof,their synthesis,and pharmaceutical formulations |
| US4581370A (en) * | 1983-07-12 | 1986-04-08 | Schering A.G. | Antiarrhythmic imidazoliums |
| JPH01316365A (en) * | 1988-03-24 | 1989-12-21 | Shikoku Chem Corp | 1-benzylimidazole compound, synthesis thereof and curing of polyepoxy resin using said compound |
-
1978
- 1978-10-18 MC MC781335A patent/MC1221A1/en unknown
- 1978-10-18 CA CA313,653A patent/CA1111433A/en not_active Expired
- 1978-10-18 IE IE2067/78A patent/IE47749B1/en unknown
- 1978-10-18 ZA ZA785863A patent/ZA785863B/en unknown
- 1978-10-18 IT IT51570/78A patent/IT1109321B/en active
- 1978-10-18 AT AT0747378A patent/AT370095B/en not_active IP Right Cessation
- 1978-10-18 AU AU40824/78A patent/AU522055B2/en not_active Expired
- 1978-10-18 DK DK464278A patent/DK464278A/en not_active Application Discontinuation
- 1978-10-18 DE DE19782845406 patent/DE2845406A1/en not_active Withdrawn
- 1978-10-18 JP JP12830378A patent/JPS5488268A/en active Granted
- 1978-10-18 FI FI783175A patent/FI783175A/en not_active Application Discontinuation
- 1978-11-02 IL IL55858A patent/IL55858A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MC1221A1 (en) | 1979-07-20 |
| ATA747378A (en) | 1982-07-15 |
| AU522055B2 (en) | 1982-05-13 |
| JPS5488268A (en) | 1979-07-13 |
| IL55858A0 (en) | 1979-01-31 |
| AT370095B (en) | 1983-02-25 |
| IE782067L (en) | 1979-04-19 |
| CA1111433A (en) | 1981-10-27 |
| FI783175A (en) | 1979-04-20 |
| JPS6233227B2 (en) | 1987-07-20 |
| IL55858A (en) | 1982-09-30 |
| DK464278A (en) | 1979-04-20 |
| IT1109321B (en) | 1985-12-16 |
| AU4082478A (en) | 1980-04-24 |
| IE47749B1 (en) | 1984-06-13 |
| ZA785863B (en) | 1980-05-28 |
| DE2845406A1 (en) | 1979-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT7850797A0 (en) | PROCEDURE FOR THE PRODUCTION OF MACROMOLECULAR COMPLEXES OBTAINED PRODUCT AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENT | |
| IT7852447A0 (en) | PROCEDURE FOR THE PREPARATION OF AMINO DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THEM AND THE PRODUCT OBTAINED | |
| IT1155862B (en) | PROCEDURE FOR THE PRODUCTION OF PYRIDINIC METHYL ESTERS SUBSTITUTED FOR CYCLOPROPANCARBOXYL ACIDS PRODUCT OBTAINED AND INSECTICIDE COMPOSITIONS THAT CONTAIN IT AS AN ACTIVE INGREDIENT | |
| IT1115800B (en) | DERIVATIVES OF THE IMIDAZOLE RELATIVE PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT | |
| IT7851659A0 (en) | PROCEDURE FOR THE PRODUCTION OF POLYSACCHARDS BY EXTRACTION FROM THE MICROBIAL BODIES OF HAEMOPHILUS INFLUENZA AND THE PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENT | |
| IT7851570A0 (en) | PROCEDURE FOR THE PRODUCTION OF IMIDAZOLE DERIVATIVES PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENT | |
| IT7869295A0 (en) | DERIVATIVES OF PHENYLYSOTHIOCYANATES PARTICULARLY USEFUL AS FUNGICIDES FOR AGRICULTURE AND PROCEDURE FOR THEIR PREPARATION | |
| IT7851815A0 (en) | NAPHTHOTRIAZOLE DERIVATIVES PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR PREPARING THEM | |
| IT1111061B (en) | PROCEDURE FOR THE PRODUCTION OF IMIDAZOBENZOSSAZINE AND THEIR SALTS PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AS IN ACTIVE INGREDIENT | |
| IT7948011A0 (en) | PROCEDURE FOR THE PREPARATION OF 2-PHENYLYMINOIMIDAZOLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PRODUCT OBTAINED | |
| IT7824170A0 (en) | DERIVATIVES OF MINUSCULATE-SUBSTITUTED OMEGA PENTIL-UREE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES. | |
| IT7850986A0 (en) | 5-IMINODAUNOMICIN AND ITS DERIVATIVES PROCEDURE FOR PREPARING IT AS WELL AS PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT | |
| IT7829133A0 (en) | DERIVATIVES OF 6-OXYGENATE-3,20-DIOXOPREGNAN, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| IT7948266A0 (en) | PROCEDURE FOR THE PREPARATION OF BICYCLOOTTANE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE PRODUCT OBTAINED | |
| IT7850877A0 (en) | PROCEDURE FOR THE PRODUCTION OF DIPEPTIDES ANALOGUE TO SOMATOSTATIN PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENT | |
| IT7851955A0 (en) | PROCEDURE FOR THE PRODUCTION OF ORIGINAL DERIVATIVES OF 5H-BENZO-CI CLOEPTEN-7-AMINE AND THEIR SALTS, OBTAINED PRODUCT AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT AS AN ACTIVE INGREDIENT | |
| IT1110868B (en) | PROCEDURE FOR THE PRODUCTION OF TETRACYCLONONIC DERIVATIVES ANTI-VIRAL PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| IT7949743A0 (en) | PROCEDURE FOR THE PREPARATION OF ACETYLENE DERIVATIVES OF ANDROST-4ENE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PRODUCT OBTAINED | |
| IT7948727A0 (en) | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF PYRROLIDINCARBOXALDEI AND PIPERIDINCARBOXALDEHYDE AND THE PRODUCT OBTAINED | |
| IT1110876B (en) | PROCEDURE FOR THE PREPARATION OF 1-HYDROXIAPORFIN DERIVATIVES AND PRODUCT OBTAINED | |
| IT1157750B (en) | PROCEDURE FOR THE PREPARATION OF 1-HYDROCARBYLPYRROL-2-ACETIC ACID DERIVATIVES AND PRODUCT OBTAINED | |
| IT7850613A0 (en) | DROST-4-ENE PROCEDURE FOR THE 17ALPHA-ACETYLENE DERIVATIVES OF ANRO PRODUCTION AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THEM AS ACTIVE INGREDIENT | |
| IT1159137B (en) | PROCEDURES FOR THE PRODUCTION OF ORGANIC COMPOUNDS, IN PARTICULAR TIENOBENZAZEPINE AND RELATED PHARMACEUTICAL COMPOSITIONS | |
| IT1164677B (en) | 1,3 BENZODIOXY DERIVATIVES PROCEDURE FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE INCREDIENTS | |
| IT1110883B (en) | PROCEDURE FOR THE PREPARATION OF SULPHOSXIMIDIC DERIVATIVES GARMICALLY ACTIVE PHARMACY AND PRODUCT OBTAINED |